your market intelligence analyst
Search Results
53 results
Your search is now limited to «Lung Cancer» expert search.
American Diabetes Journals 08/20/2019 15:00
OBJECTIVE. The Follow-Up Study of patients previously enrolled in Exubera controlled clinical trials (FUSE) was designed to evaluate whether patients previously treated with Exubera (EXU; insulin human [rDNA origin], inhaled powder) in controlled clinical trials died because of incident primary lung cancer at a substantially higher rate than patients treated with a comparator. RESEARCH DESIGN AND METHODS. FUSE is a hybrid, randomized, controlled trial/cohort study including participants of 17 prior EXU clinical trials. 08/20/2019 07:21
Conditions : Lung Non-Small Cell Carcinoma; Stage I Lung Cancer AJCC v8; Stage IA1 Lung Cancer AJCC v8; Stage IA2 Lung Cancer AJCC v8; Stage IA3 Lung Cancer AJCC v8; Stage IB Lung Cancer AJCC v8; Stage II Lung Cancer AJCC v8; Stage IIA Lung Cancer AJCC v8; Stage IIB Lung Cancer AJCC v8; Stage IIIA Lung Cancer AJCC v8 Interventions : Drug: Cisplatin; Biological: Pembrolizumab; Drug: Pemetrexed; Drug: Pemetrexed Disodium; Procedure: Therapeutic Conventional Surgery Sponsors : University of California, San Francisco; Merck Sharp & Dohme Corp. Not yet recruiting.

Automotive Industries

Business Issues

Companies - Public

Companies - Venture Funded

Global Markets

Government Agencies

Information Technologies

Job Titles

Legal and Regulatory

Market Research Topics

Political Entities


Strategic Scenarios